Synthesis of an S1P1 Agonist

S. R. Fix-Stenzel; M. E. Hayes; X. Zhang; G. A. Wallace; P. Grongsaard; L. M. Schaffter; S. M. Hannick; T. S. Franczyk; R. H. Stoffel; K. P. Cusack

doi:10.1055/s-0029-1217868

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synfacts 2009(10): 1061-1061
DOI: 10.1055/s-0029-1217868

Synthesis of Natural Products and Potential Drugs

Synthesis of an S1P₁ Agonist

Contributor(s): Philip Kocienski
S. R. Fix-Stenzel, M. E. Hayes*, X. Zhang, G. A. Wallace, P. Grongsaard, L. M. Schaffter, S. M. Hannick, T. S. Franczyk, R. H. Stoffel, K. P. Cusack
Abbott Laboratories, Abbott Park and Abbott Research Center, Worcester, USA

Further Information

Publication History

Publication Date:
22 September 2009 (online)

Permissions and Reprints

Significance

The sphingosine-1-phosphate (S1P₁) receptor is involved in the sequestration of lymphocytes into secondary organs thereby preventing them from causing an autoimmune response. Agonism of the S1P₁ receptor may offer a treatment for multiple sclerosis. The target molecule induces lymphocyte sequestration in mice.